Interpregnancy Interval and Risk of Autism Spectrum Disorders

Ousseny Zerbo1, Cathleen Yoshida2, Erica P Gunderson2

  • 1Division of Research, Kaiser Permanente Northern California, Oakland, California; and ousseny.x.zerbo@kp.org.

Pediatrics
|September 16, 2015
PubMed

Insights

Short or long interpregnancy intervals (IPIs) increase autism spectrum disorder (ASD) risk. Children born less than two years or more than six years apart face a higher risk of ASD development.

Area of Science:

  • Reproductive health
  • Pediatric neurology
  • Epidemiology

Background:

  • Interpregnancy intervals (IPIs) are crucial factors in maternal and child health outcomes.
  • Previous research suggests potential links between IPIs and various adverse pregnancy and birth outcomes.
  • The association between IPIs and the risk of autism spectrum disorder (ASD) requires further investigation.

Purpose of the Study:

  • To investigate the association between short (<12 months) and long (≥72 months) interpregnancy intervals (IPIs) and the risk of autism spectrum disorder (ASD) in subsequent births.
  • To quantify the risk of ASD associated with different IPI lengths.

Main Methods:

  • A cohort study of 45,261 children born between 2000 and 2009 at Kaiser Permanente Northern California (KPNC) was conducted.
  • Children with ASD were identified using International Classification of Diseases, Revision 9 diagnostic codes.
  • Survival analysis and logistic regression models were employed to assess the association between IPI and ASD risk, adjusting for potential confounders.

Main Results:

  • Children born after an IPI of <12 months or ≥72 months demonstrated a 2- to 3-fold increased risk of ASD compared to those with an IPI of 36 to 47 months.
  • Specific adjusted hazard ratios indicated elevated risks for intervals <6 months (3.0), 6-8 months (2.1), 9-11 months (1.9), 12-23 months (1.5), and ≥72 months (2.4).
  • These associations remained significant after accounting for maternal BMI, parental age, and medication use.

Conclusions:

  • Interpregnancy intervals of less than 2 years or greater than 6 years may be associated with an increased risk of autism spectrum disorder (ASD) in children.
  • The underlying biological or environmental mechanisms driving this association are currently unknown and warrant further research.
  • These findings highlight the importance of considering IPI in the context of neurodevelopmental outcomes.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
63